World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
90
Citations
44656
World Ranking
11981
National Ranking
6142

Neuroscience

D-Index
90
Citations
44531
World Ranking
1091
National Ranking
566

Roy Freeman publication distribution in Neuroscience in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Neuroscience in 2026. The highlighted bar marks where Roy Freeman sits on this spectrum.

38–47 publications: 18 scientists 48–57 publications: 79 scientists 58–67 publications: 193 scientists 68–77 publications: 323 scientists 78–87 publications: 406 scientists 88–97 publications: 452 scientists 98–107 publications: 539 scientists 108–117 publications: 505 scientists 118–127 publications: 522 scientists 128–137 publications: 469 scientists 138–147 publications: 456 scientists 148–157 publications: 459 scientists 158–167 publications: 397 scientists 168–177 publications: 383 scientists 178–187 publications: 350 scientists 188–197 publications: 302 scientists 198–207 publications: 306 scientists 208–217 publications: 262 scientists 218–227 publications: 242 scientists 228–237 publications: 220 scientists 238–247 publications: 203 scientists 248–257 publications: 174 scientists 258–267 publications: 176 scientists 268–277 publications: 175 scientists 278–287 publications: 125 scientists 288–297 publications: 116 scientists 298–307 publications: 127 scientists 308–317 publications: 128 scientists 318–327 publications: 99 scientists 328–337 publications: 89 scientists 338–347 publications: 78 scientists 348–357 publications: 96 scientists 358–367 publications: 66 scientists 368–377 publications: 59 scientists 378–387 publications: 65 scientists 388–397 publications: 54 scientists 398–407 publications: 48 scientists 408–417 publications: 49 scientists 418–427 publications: 34 scientists 428–437 publications: 31 scientists 438–447 publications: 30 scientists 448–457 publications: 31 scientists 458–467 publications: 36 scientists 468–477 publications: 40 scientists 478–487 publications: 35 scientists 488–497 publications: 30 scientists 498–507 publications: 23 scientists 508–517 publications: 26 scientists 518–527 publications: 20 scientists 528–537 publications: 23 scientists 538–547 publications: 20 scientists 548–557 publications: 20 scientists 558–567 publications: 17 scientists 568–577 publications: 14 scientists 578–587 publications: 20 scientists 588–597 publications: 20 scientists 598–607 publications: 19 scientists 608–617 publications: 18 scientists 618–627 publications: 17 scientists 628–637 publications: 11 scientists 638–647 publications: 11 scientists 648–657 publications: 11 scientists 658–667 publications: 8 scientists 668–677 publications: 7 scientists 678–687 publications: 11 scientists 688–697 publications: 10 scientists 698–707 publications: 4 scientists 708–717 publications: 6 scientists 718–727 publications: 5 scientists 728–737 publications: 5 scientists 738–747 publications: 9 scientists 748–757 publications: 9 scientists 758–767 publications: 3 scientists 768–777 publications: 7 scientists 778–787 publications: 7 scientists 788–797 publications: 6 scientists 798–807 publications: 2 scientists 808–817 publications: 2 scientists 818–827 publications: 7 scientists 828–837 publications: 0 scientists 838–847 publications: 9 scientists 848–857 publications: 3 scientists 858–867 publications: 1 scientists 868–877 publications: 3 scientists 878–886 publications: 6 scientists 887+ publications: 100 scientists
38 publications 887+

This scientist: 334 publications — 86th percentile

86% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 887 publications or more.

Roy Freeman D-index placement in Neuroscience in 2026

The chart shows the D-index (discipline H-index) distribution of Neuroscience scientists ranked by Research.com in 2026. The highlighted bar marks where Roy Freeman sits on this spectrum.

30–31 D-Index: 42 scientists 32–33 D-Index: 172 scientists 34–35 D-Index: 296 scientists 36–37 D-Index: 435 scientists 38–39 D-Index: 459 scientists 40–41 D-Index: 456 scientists 42–43 D-Index: 467 scientists 44–45 D-Index: 478 scientists 46–47 D-Index: 512 scientists 48–49 D-Index: 435 scientists 50–51 D-Index: 425 scientists 52–53 D-Index: 418 scientists 54–55 D-Index: 392 scientists 56–57 D-Index: 357 scientists 58–59 D-Index: 334 scientists 60–61 D-Index: 328 scientists 62–63 D-Index: 260 scientists 64–65 D-Index: 278 scientists 66–67 D-Index: 239 scientists 68–69 D-Index: 250 scientists 70–71 D-Index: 210 scientists 72–73 D-Index: 200 scientists 74–75 D-Index: 189 scientists 76–77 D-Index: 170 scientists 78–79 D-Index: 146 scientists 80–81 D-Index: 113 scientists 82–83 D-Index: 126 scientists 84–85 D-Index: 100 scientists 86–87 D-Index: 84 scientists 88–89 D-Index: 99 scientists 90–91 D-Index: 84 scientists 92–93 D-Index: 85 scientists 94–95 D-Index: 72 scientists 96–97 D-Index: 76 scientists 98–99 D-Index: 45 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 43 scientists 104–105 D-Index: 32 scientists 106–107 D-Index: 45 scientists 108–109 D-Index: 50 scientists 110–111 D-Index: 32 scientists 112–113 D-Index: 39 scientists 114–115 D-Index: 32 scientists 116–117 D-Index: 29 scientists 118–119 D-Index: 27 scientists 120–121 D-Index: 19 scientists 122–123 D-Index: 23 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 16 scientists 128–129 D-Index: 24 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 21 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 14 scientists 138–139 D-Index: 15 scientists 140–141 D-Index: 10 scientists 142–143 D-Index: 10 scientists 144–145 D-Index: 13 scientists 146–147 D-Index: 9 scientists 148–149 D-Index: 8 scientists 150–151 D-Index: 6 scientists 152–153 D-Index: 6 scientists 154–155 D-Index: 7 scientists 156–157 D-Index: 7 scientists 158–159 D-Index: 10 scientists 160–161 D-Index: 4 scientists 162 D-Index: 8 scientists 163+ D-Index: 100 scientists
30 D-Index 163+

This scientist: 90 D-Index — 89th percentile

89% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 163 D-Index or more.

Overview

Roy Freeman is affiliated with Beth Israel Deaconess Medical Center in the United States. Their research focus lies predominantly within the field of Medicine, with significant contributions to Neurology, Cardiology and Cardiovascular Medicine, Physiology, Surgery, and Cellular and Molecular Neuroscience.

Their work spans numerous topics, including:

  • Parkinson's Disease Mechanisms and Treatments
  • Botulinum Toxin and Related Neurological Disorders
  • Neurological disorders and treatments
  • Pain Mechanisms and Treatments
  • Heart Rate Variability and Autonomic Control
  • Cardiovascular Syncope and Autonomic Disorders
  • Musculoskeletal pain and rehabilitation

Roy Freeman has published extensively in several medical journals, with a high frequency of articles appearing in:

  • Neurology
  • Pain
  • Autonomic Neuroscience
  • Movement Disorders
  • Clinical Autonomic Research

Frequent co-authors who have collaborated with Roy Freeman include:

  • Christopher H. Gibbons
  • Todd Levine
  • Robert H. Dworkin
  • Bailey Bellaire
  • Jennifer S. Gewandter

Some of the recent published papers authored or co-authored by Roy Freeman are:

  • The Movement Disorder Society Criteria for the Diagnosis of Multiple System Atrophy, 2022, Movement Disorders
  • Postural orthostatic tachycardia syndrome (POTS): State of the science and clinical care from a 2019 National Institutes of Health Expert Consensus Meeting - Part 1, 2021, Autonomic Neuroscience
  • Screening, diagnosis and management of diabetic sensorimotor polyneuropathy in clinical practice: International expert consensus recommendations, 2021, Diabetes Research and Clinical Practice
  • Electrodiagnostic assessment of the autonomic nervous system: A consensus statement endorsed by the American Autonomic Society, American Academy of Neurology, and the International Federation of Clinical Neurophysiology, 2020, Clinical Neurophysiology
  • Interpretation of chronic pain clinical trial outcomes: IMMPACT recommended considerations, 2020, Pain

Best Publications

  • Diabetic Neuropathies: Update on Definitions, Diagnostic Criteria, Estimation of Severity, and Treatments

    Solomon Tesfaye;Andrew J.M. Boulton;Peter J. Dyck;Roy Freeman

  • Diabetic neuropathies: a statement by the American Diabetes Association.

    Andrew J.M. Boulton;Andrew J.M. Boulton;Arthur I. Vinik;Joseph C. Arezzo;Vera Bril

  • Diabetic Autonomic Neuropathy

    Aaron I. Vinik;Raelene E. Maser;Braxton D. Mitchell;Roy Freeman

  • Diabetic Neuropathy: A Position Statement by the American Diabetes Association

    Rodica Pop-Busui;Andrew J.M. Boulton;Eva L. Feldman;Vera Bril

  • Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome.

    Roy Freeman;Wouter Wieling;Felicia B. Axelrod;David G. Benditt

  • Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome

    Roy Freeman;Wouter Wieling;Felicia B. Axelrod;David G. Benditt

  • Consensus statement on the definition of orthostatic hypotension, pure autonomic failure, and multiple system atrophy

    I. J. Schatz;R. Bannister;R. L. Freeman;C. G. Goetz

  • Neuropathic pain: An updated grading system for research and clinical practice

    Nanna B. Finnerup;Simon Haroutounian;Peter Kamerman;Ralf Baron

  • Cardiovascular autonomic neuropathy in diabetes: clinical impact, assessment, diagnosis, and management

    Vincenza Spallone;Dan Ziegler;Roy Freeman;Luciano Bernardi

  • The Association Between Cardiovascular Autonomic Neuropathy and Mortality in Individuals With Diabetes: A meta-analysis

    Raelene E. Maser;Braxton D. Mitchell;Aaron I. Vinik;Roy Freeman

  • The Movement Disorder Society Criteria for the Diagnosis of Multiple System Atrophy

    Unknown

  • Efficacy of midodrine vs placebo in neurogenic orthostatic hypotension. A randomized, double-blind multicenter study. Midodrine Study Group.

    Phillip A. Low;Janice L. Gilden;Roy Freeman;Ke Ning Sheng

  • Value of quantitative sensory testing in neurological and pain disorders: NeuPSIG consensus.

    Miroslav Misha Backonja;Nadine Attal;Ralf Baron;Didier Bouhassira

  • Neurogenic Orthostatic Hypotension

    Roy Freeman

  • Efficacy and Safety of Antioxidant Treatment With α-Lipoic Acid Over 4 Years in Diabetic Polyneuropathy: The NATHAN 1 trial

    Dan Ziegler;Phillip A. Low;William J. Litchy;Andrew J.M. Boulton

  • Endothelial dysfunction and the expression of endothelial nitric oxide synthetase in diabetic neuropathy, vascular disease, and foot ulceration.

    Aristidis Veves;Cameron M. Akbari;James Primavera;Valerie M. Donaghue

  • The recommendations of a consensus panel for the screening, diagnosis, and treatment of neurogenic orthostatic hypotension and associated supine hypertension

    Christopher H. Gibbons;Peter Schmidt;Italo Biaggioni;Camille Frazier-Mills

  • Efficacy and Safety of Recombinant Human Nerve Growth Factor in Patients With Diabetic Polyneuropathy: A Randomized Controlled Trial

    Apfel Sc;Schwartz S;Adornato Bt;Freeman R

  • Patient phenotyping in clinical trials of chronic pain treatments: IMMPACT recommendations

    Robert R. Edwards;Robert H. Dworkin;Dennis C. Turk;Martin S. Angst

  • Efficacy, safety, and tolerability of pregabalin treatment for painful diabetic peripheral neuropathy: findings from seven randomized, controlled trials across a range of doses.

    Roy Lester Freeman;Edith Durso-DeCruz;Birol Emir

  • Hemodynamic and autonomic nervous system responses to mixed meal ingestion in healthy young and old subjects and dysautonomic patients with postprandial hypotension.

    L A Lipsitz;S M Ryan;J A Parker;R Freeman

  • Diabetic Neuropathy: A cross sectional study of the relationships among tests of neurophysiology

    Christopher H. Gibbons;Roy Freeman;Aristidis Veves

Frequent Co-Authors

Horacio Kaufmann
Horacio Kaufmann New York University
Phillip A. Low
Phillip A. Low Mayo Clinic
Robert H. Dworkin
Robert H. Dworkin University of Rochester Medical Center
Italo Biaggioni
Italo Biaggioni Vanderbilt University Medical Center
David Robertson
David Robertson Vanderbilt University
Aaron I. Vinik
Aaron I. Vinik Eastern Virginia Medical School
Robert R. Edwards
Robert R. Edwards Brigham and Women's Hospital
Max J. Hilz
Max J. Hilz University of Erlangen-Nuremberg
Dennis C. Turk
Dennis C. Turk University of Washington
Gail K. Adler
Gail K. Adler Brigham and Women's Hospital

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Neuroscience opens doors to many interdisciplinary career paths, particularly in mental health, counseling, and allied psychology fields. For those interested in clinical roles, consider programs like an accelerated msw (Master of Social Work), which can fast-track your entry into social services or case management.

If you’re leaning toward behavioral research, therapy, or basic psychology, pursuing an accelerated psychology degree online might be a suitable fit. These programs enable you to complete your bachelor’s or master’s studies more quickly, combining foundational neuroscience knowledge with critical human behavior training.

Aspiring counselors may benefit from exploring online mental health counseling programs, which are often designed to meet current industry standards and offer flexibility for working professionals.

For maximum affordability and accessibility, a masters in counseling is another promising route that aligns well with neuroscience foundations. Each path enables graduates to combine scientific understanding with people-focused practice, widening career potential in wellness and healthcare sectors.

Best Scientists Citing Roy Freeman

Trending Scientists

Recently Published Articles